Great Lakes NeuroTechnologies Inc.
20
0
0
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
1 terminated/withdrawn out of 20 trials
94.4%
+7.9% vs industry average
0%
0 trials in Phase 3/4
18%
3 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System
Role: lead
Objective Quality of Life Detection Validation
Role: lead
Patient-Centered PD Ambulatory Monitoring System
Role: lead
Automated Deep Brain Stimulation Programming Using Functional Mapping
Role: lead
CPAP vs AutoCPAP for Treatment of Obstructive Sleep Apnea (OSA) in the Postoperative Setting
Role: collaborator
Kinesia 360 Parkinson's Monitoring Study
Role: lead
Movement Disorder Quantification Algorithm Development
Role: lead
BradyXplore Phase II: Bradykinesia Feature Extraction System
Role: lead
Pilot Study for Automated Deep Brain Stimulation Programming
Role: lead
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
Role: lead
Kinesia HomeView - Home Diary Comparison
Role: lead
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Role: lead
MyoSense- Automated Muscle Hypertonicity Classification System
Role: lead
ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease
Role: lead
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
Role: lead
Continuous Tremor Assessment During Daily Activities
Role: lead
Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming
Role: lead
Tele-diagnostics for Remote Parkinson's Monitoring
Role: lead
Adaptive Portable Essential Tremor Monitor
Role: lead
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Role: lead
All 20 trials loaded